scholarly journals 850 Management of congenital adrenal hyperplasia in a paediatric endocrinology center over the past 20 years

Author(s):  
Antony Fu ◽  
Eunice Wong ◽  
Eunice Wong
1974 ◽  
Vol 50 (5) ◽  
pp. 897-907,889
Author(s):  
Akira KUMAGAI ◽  
Masahiro YAMAMOTO ◽  
Tetsuo NISHIKAWA ◽  
Yasushi TAMURA ◽  
Yutaka SUZUKI ◽  
...  

Author(s):  
Sumudu N. Seneviratne ◽  
Udara Sandakelum ◽  
Chaminda H. Jayawardena ◽  
Ashangi M. Weerasinghe ◽  
Piyumi S. Wickramarachchi ◽  
...  

Abstract Objectives Although new-born screening (NBS) for classical congenital adrenal hyperplasia (C-CAH) has been available for decades, it is not widely implemented. We assessed the usefulness of introducing NBS for C-CAH, by analyzing presenting status of infants with C-CAH, over the past two decades, in Sri Lanka. Methods This retrospective clinic-based study, from the largest tertiary children’s hospital in Sri Lanka, analyzed initial presenting features of children with C-CAH from 1999 to 2018, in the absence of NBS for CAH, and included gender-based comparisons. Results Features suggestive of impending adrenal-crisis were seen at initial presentation in >80 % (dehydration 70%, hyponatremia 65%, hyperkalemia 47%, vomiting 45%, hypoglycemia 22%, collapse 20%). Hyperpigmentation was seen in 78%, and consanguinity in 27%. There were fewer affected males (n = 12) compared to females (n = 28). Most girls (96%) had virilized genitalia, and 16 faced uncertainty about gender at birth. Median age at diagnosis was 20 days. More than 70% of children had SW-CAH (males = 9 and females = 20). There were fewer males with SW-CAH, and all had features of impending adrenal crisis, including severe hyponatremia in 50%, while 62% of girls also developed hyponatremia and 33% had hyperkalemia, prior to treatment. Treatment of SW-CAH was initiated at a median age of 30 days in boys, and 10 days of age in girls. Conclusion Many boys and girls with C-CAH from Sri Lanka presented late with impending adrenal crisis. Males were diagnosed later, and some possibly succumbed to C-CAH undiagnosed. These findings support including CAH in NBS programs to avert preventable childhood morbidity and mortality.


PEDIATRICS ◽  
1968 ◽  
Vol 41 (5) ◽  
pp. 871-872
Author(s):  
Alfred M. Bongiovanni

A Relationship between the kidney and hypertension has been recognized for centuries. For the past three decades various manipulations of the kidney, beginning with the "Goldblatt kidney," have been known to produce hypertension. Thus, it has long been suspected that some humoral factor originating in renal tissue was involved. There is now evidence that this renal factor is renin and it appears to originate in the juxtaglomerular apparatus. The exact mode of its release is not entirely clear, but it seems probable that subtle changes in blood volume or perhaps blood viscosity play a role. Hormonal control has not been ruled out. It is known that sodium depletion leads to increased release of renin.


F1000Research ◽  
2015 ◽  
Vol 4 ◽  
pp. 601 ◽  
Author(s):  
Phyllis W. Speiser

Congenital adrenal hyperplasia associated with deficiency of steroid 21-hydroxylase is the most common inborn error in adrenal function and the most common cause of adrenal insufficiency in the pediatric age group. As patients now survive into adulthood, adult health-care providers must also be familiar with this condition. Over the past several years, F1000 has published numerous commentaries updating research and practical guidelines for this condition. The purposes of this review are to summarize basic information defining congenital adrenal hyperplasia and to highlight current knowledge and controversies in management.


2021 ◽  
Vol 7 (3) ◽  
pp. 36
Author(s):  
Atsumi Tsuji-Hosokawa ◽  
Kenichi Kashimada

Congenital adrenal hyperplasia (CAH) is an inherited disorder caused by the absence or severely impaired activity of steroidogenic enzymes involved in cortisol biosynthesis. More than 90% of cases result from 21-hydroxylase deficiency (21OHD). To prevent life-threatening adrenal crisis and to help perform appropriate sex assignments for affected female patients, newborn screening (NBS) programs for the classical form of CAH have been introduced in numerous countries. In Japan, the NBS for CAH was introduced in 1989, following the screenings for phenylketonuria and congenital hypothyroidism. In this review, we aim to summarize the experience of the past 30 years of the NBS for CAH in Japan, composed of four parts, 1: screening system in Japan, 2: the clinical outcomes for the patients with CAH, 3: various factors that would impact the NBS system, including timeline, false positive, and LC-MS/MS, 4: Database composition and improvement of the screening program.


2007 ◽  
Vol 177 (4S) ◽  
pp. 307-307
Author(s):  
Ariella Hochsztein ◽  
Rebecca Baergen ◽  
Emily Loyd ◽  
Jie Chen ◽  
Diane Felsen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document